“…Fluorescent sensors have flourished in disease diagnosis in recent years due to their noninvasiveness, high sensitivity, and good selectivity. − In the pathogenesis of NAFLD, excessive accumulation of lipids in hepatocytes is accompanied by the alterations in the intracellular microenvironment. − The viscosity increase in a cellular environment is a distinct change in the progression of NAFLD, and high viscosity is considered as a biomarker of NAFLD. , Several viscosity-sensitive probes have been reported for the diagnosis of NAFLD. − Because viscosity increase also occurs in other liver diseases, detecting viscosity change alone may lead to false interpretations of NAFLD. − Simultaneously detecting two biomarkers of diseases can effectively avoid false-positive results, in turn highly improving the disease diagnostic accuracy. Therefore, dual-biomarker-activated fluorescent probes are more suitable for accurate disease diagnosis than single-biomarker-activated ones.…”